Biocept (BIOC) Reports Q3 Loss of $2.42/Share

Biocept (NASDAQ: BIOC) reported Q3 EPS of ($2.42), versus ($5.90) reported last year. Revenue for the quarter came in at $762 thousand, versus $1.1 million reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• BofA expects Apple to top analyst expectations on July 30
• Domino's Q2 2026 earnings call rescheduled to 11 a.m. ET after webcast issues
• Golden State Water seeks CPUC approval for $5.25M Norwalk system buy